http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0025808-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e18f414d0bab1dae1ed4478ac9e66935
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0053c25f3331ddbc91dd14c908da1843
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_88fd7a27b260c92ad6f34503c1525678
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b43aef2ec46f175564b0143d6af125c8
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2896
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-177
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0783
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-07
filingDate 1999-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a90b46723720bd00895a97f95099b9f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c02de8574ec6f698a6ea85393420fc79
publicationDate 2000-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-0025808-A1
titleOfInvention Inhibition of differentiation of cytotoxic t-cells by p-selectin ligand (psgl) antagonists
abstract Methods are disclosed for inhibiting the differentiation of an activated T-cell into a cytotoxic lymphocyte in a mammalian subject, comprising administering to a subject a therapeutically effective amount of a PSGL antagonist.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8557579-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007067983-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8828397-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1534332-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012092144-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9631019-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8287871-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8298540-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1534332-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11155791-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7744888-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10030075-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2002305041-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8628775-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1985634-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7223848-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11162085-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007067983-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8361472-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11168311-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9494574-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7604800-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8663641-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1714982-A3
priorityDate 1998-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5659018-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5827817-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413191
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5789
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1134
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129854253
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID522325
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16759173
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226429351
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409524
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226429352
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226416391
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409525
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226416392
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395298
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409529
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4929
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128571533
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5287620
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21941209
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226681559
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57472993
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66587598
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1738118
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127376540
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID643990
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18729306
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226398978

Total number of triples: 84.